Medical Equipment

Liver Cancer Diagnostics Market Trends, Drivers, and Regional Analysis 2025–2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the liver cancer diagnostics market from 2025–2034 with trusted insights from The Business Research Company

How Is The Liver Cancer Diagnostics Market Size Expected To Expand Over 2029-2034?

The liver cancer diagnostics market size has seen substantial growth in recent years. This market is set to expand from $9.69 billion in 2024 to $10.32 billion in 2025, showing a compound annual growth rate (CAGR) of 6.5%. The historical growth can be attributed to developments in biopsy techniques and histopathology, advancements in biomarker detection, the evolution of screening programs, progress in genetic testing, and enhanced liver imaging modalities.

The liver cancer diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $13.71 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period is driven by factors such as evolving regulatory frameworks and standardization, the increasing significance of imaging techniques, advancements in next-generation sequencing, wider screening initiatives and public awareness, and a surging need for biomarker-based tests. Key trends anticipated for this period encompass an increase in the occurrence and spread of the disease, breakthroughs in imaging technologies, an emphasis on diagnostic methods that are non-invasive, the development of precision medicine and individualized diagnostics, and the incorporation of artificial intelligence (AI).

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10481&type=smp

Which Market Factors Are Fueling The Liver Cancer Diagnostics Industry Growth?

The escalating incidence of liver cancer is anticipated to fuel the expansion of the liver cancer diagnostics market moving forward. This severe condition involves liver cells growing and multiplying uncontrollably. Liver cancer diagnostic tests are performed to determine whether cancer cells are spreading within or surrounding the liver after a primary liver carcinoma diagnosis, thus the growing prevalence of liver cancer stimulates the liver cancer diagnostics market. For illustration, a report titled Cancer Facts & Figures 2023, released in January 2023 by the US-based voluntary health organization, the American Cancer Society, indicated that new cases of liver and intrahepatic bile duct cancer in females in the United States climbed to 13,230 in 2023, up from 12,640 in 2020. Furthermore, in 2023, an estimated 41,210 new cases of liver cancer are projected to be diagnosed in the US, with 29,380 people expected to succumb to the disease. Consequently, the increasing prevalence of liver cancer is a significant factor driving the growth of the liver cancer diagnostic market.

Which Categories Are Covered In The Liver Cancer Diagnostics Market Segmentation Analysis?

The liver cancer diagnosticsmarket covered in this report is segmented –

1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types

2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings

3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories

Subsegments:

1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma

2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma

3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma

4) Other Types: Secondary Liver Cancer, Fibrolamellar Carcinoma

Which Market Trends Are Expected To Define The Future Of The Liver Cancer Diagnostics Market?

Leading companies in the liver cancer diagnostics market are developing advanced biomarker-based assays and algorithms to enhance diagnostic accuracy and support early detection. These biomarker-based assays and algorithms are diagnostic tools that utilize specific biological markers to identify diseases, offering more precise and efficient diagnostic capabilities. For example, in November 2023, Roche Diagnostics, a US-based biotech corporation, introduced the Elecsys PIVKA-II assay and Elecsys GAAD algorithm. The Elecsys PIVKA-II assay identifies elevated levels of the PIVKA-II biomarker, which is linked to hepatocellular carcinoma (HCC), thereby improving early detection of liver cancer in high-risk patients. The Elecsys GAAD algorithm integrates multiple diagnostic markers, such as PIVKA-II and AFP, to further enhance diagnostic precision and streamline decision-making in liver cancer detection.

Which Organizations Are At The Forefront Of The Liver Cancer Diagnostics Market?

Major companies operating in the liver cancer diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen NV, Thermo Fisher Scientific Inc., Siemens Healthineers, Illumina Inc., Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc., Danaher Corporation, Foundation Medicine Inc., Agilent Technologies Inc., Genemed Biotechnologies Inc., Merck KGaA, Fujifilm Medical Systems USA Inc., GE Healthcare, Advanced Cell Diagnostics Inc., Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon A/S, BioGenex Laboratories Inc., OncoCyte Corporation, Guardant Health Inc., Exact Sciences Corporation, Grail Inc., Freenome Holdings Inc., Natera Inc., Personal Genome Diagnostics Inc., Thrive Earlier Detection Corp

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Liver Cancer Diagnostics Market?

North America was the largest region in the liver cancer diagnostics market in 2024. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10481&type=smp

Browse Through More Reports Similar to the Global Liver Cancer Diagnostics Market 2025, By The Business Research Company

Molecular Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795